Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
Title
[
Type
]
Year
Filters:
Author
is
Avigan, David E
[Clear All Filters]
Journal Article
Pyzer AR
,
Avigan DE
,
Rosenblatt J
.
Clinical trials of dendritic cell-based cancer vaccines in hematologic malignancies.
Hum Vaccin Immunother. 2014;10(11):3125-3131.
PubMed
Google Scholar
Armand P
,
Nagler A
,
Weller EA
,
Devine SM
,
Avigan DE
,
Bin Chen Y-
,
Kaminski MS
,
H Holland K
,
Winter JN
,
Mason JR
, et al.
Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial.
J Clin Oncol. 2013.
PubMed
Google Scholar
Avigan ZM
,
Dias AL
,
Dodge LE
,
Arnason JE
,
Joyce RM
,
Liegel J
,
Rosenblatt J
,
Weinstock MJ
,
Avigan DE
,
Haspel RL
.
High CD34-positive cell dose in matched unrelated donor allogeneic hematopoietic stem cell transplant is not associated with graft-versus-host disease or mortality.
Transfusion. 2024.
PubMed
Google Scholar
Foss FM
,
Wang XVictoria
,
Luger SM
,
Jegede O
,
Miller KB
,
Stadtmauer EA
,
Whiteside TL
,
Avigan DE
,
Gascoyne RD
,
Arber D
, et al.
Incorporation of extracorporeal photopheresis into a reduced intensity conditioning regimen in myelodysplastic syndrome and aggressive lymphoma: results from ECOG 1402 and 1902.
Transfusion. 2020.
PubMed
Google Scholar